Effect of Nizatidine versus Ranitidine on Gastric Intraluminal Prostaglandin Release in Duodenal Ulcer Patients

References

• Genco A, Materia A, Mariani P, et al. Gastric intraluminal prostaglandin E2 in 246 patients undergoing upper gastrointestinal endoscopy. Gastroenterology 1988; 94: A144
   Google Scholar
• Hiller K, Smith C L, Jewell R, Arthur M JP, Ross G. Duodenal mucosa synthesis of prostaglandins in duodenal ulcer disease. Gut 1985; 26: 237–40
   PubMedGoogle Scholar
• Hinsdale J G, Engel J J, Wilson D E. Prostaglandin E in peptic ulcer disease. Prostaglandins 1974; 6: 495–500
   PubMedGoogle Scholar
• Postius S, Ruoff H J, Szelenyi I. Prostaglandin formation by isolated gastric parietal and non parietal cells of the rat. Br J Pharmacol 1985; 84: 871–7
   PubMed Web of Science ®Google Scholar
• Robert A. Role of endogenous and exogenous prostaglandins in mucosal protection. Mechanism of mucosal protection in the upper gastrointestinal tract, Allen, et al. Raven Press, New York 1984; 377–82
   Google Scholar
• Sharon P, Choen F, Zifroni A, et al. Prostanoid synthesis by cultured gastric and duodenal mucosa: possible role in the pathogenesis of duodenal ulcer. Scand J Gastroenterol 1983; 18: 1045–89
   PubMed Web of Science ®Google Scholar
• Segawa Y, Takei M, Omata T, et al. Effects of the new antiulcer drug nizatidine on prostaglandins in the rat gastric mucosa. Arzneim-Forsch/Drug Res 1991; 9: 41
   Google Scholar
• Alquist D A, Dozoios R R, Zinmeister A R, Malagela J-R. Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer disease. Gastroenterology 1983; 18: 1045–9
   Google Scholar
• Goldman G, Tiomny E, Halpern Z, et al. Prostaglandin E2 in duodenal ulcer complications. Am Surgeon 1992; 58: 49–52
   PubMedGoogle Scholar
• Rachmilewitz D, Ligumsky M, Fich A, Goldin E, Eliakim A, Karmeli F. Role of endogeneous gastric prostanoids in the pathogenesis and therapy of duodenal ulcer. Gastroenterology 1986; 90: 963–9
   PubMed Web of Science ®Google Scholar
• Spaziani E, Silecchia G, Materia A, et al. Nizatidine stimulates gastric intraluminal prostaglandin release in man. Gastroenterology 1991; 100: A166
   Google Scholar
• Kauffman G L, Grossman M I. Prostaglandins and cimetidine inhibit the formation of ulcer produced by parenteral salicylates. Gastroenterology 1978; 75: 1099–102
   PubMed Web of Science ®Google Scholar
• Basso N, Materia A, et al. Gastric mucosal prostaglandin content in rats following cimetidine administration. Gastroenterology 1981; 80: 1106
   Google Scholar
• Arakawa T, Satoh H, Fukuda T, et al. Gastric mucosal resistance and prostanoid levels after cimetidine in rats. Digestion 1988; 41: 1–8
   PubMedGoogle Scholar
• Kubota K, Sugaya K, Hotta K. Effects of cimetidine on prostanoid production in the gastric corpus specimens from rats. Japan J Pharmacol 1988; 481: 491–3
   Google Scholar
• Branski D, Sharon P, Karmeli F, Rachmilewitz D. Effect of cimetidine on human gastric and duodenal prostanoid synthesis. Scand J Gastroenterol 1984; 19: 457–60
   PubMed Web of Science ®Google Scholar
• Koboyashi K, Nakamura H, Arakaza T. Secretagogues stimulate prostaglandin synthesis and inhibit mucosal damage induced by a necrotizing agent in rat gastric mucosa. J Clin Gastroenterology 1989; 10(Suppl 1)S133–9
   Google Scholar
• Arakawa T, Nakamura H. Roles of prostaglandins in the protection of gastric mucosa. Protection of gastric mucosa, T Takemoto, K Kobayashi. Ishiyaku Publ. Inc., Tokyo 1985; 32–4
   Google Scholar
• Takano K, Sugiyama H, Goto H, et al. Effect of the H2 blocker famotidine on gastric mucosal prostaglandin levels in water immersion stress in rats. Drug Res 1988; 3: 364–6
   Google Scholar
• Andreone P, Baraldini M, Micheletti E, et al. Influence of cimetidine in low doses on prostanoid release by human gastric mucosa in vitro. Drugs Exp Clin Res 1989; IV(2)91–6
   Google Scholar
• Marshall B M, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1331–4
   Google Scholar
• Silecchia G, Materia A, Spaziani E, et al. Effect of H2-receptor antagonists on gastric luminal prostaglandin E2 in the chronic gastric fistula rat. Gastroenterology 1987; 92: 1640
   Google Scholar
• Silecchia G, Materia A, Spaziani E, et al. Nizatidine stimulates intraluminal prostaglandin release in the rat. Am J Gastroenterol 1989; 84(9)1169
   Google Scholar
• Silecchia G, Materia A, Spaziani E, D'Alessandro M D, Genco A, Basso N. Effect of nizatidine on gastric intraluminal prostaglandin release in the rat. Gastroenterology 1990; 98: A124
   Google Scholar
• Peskar B M, Gunter B, Peskar B A. Prostaglandins and prostaglandin metabolites in human gastric juice. Prostaglandins 1980; 20: 419–27
   PubMed Web of Science ®Google Scholar
• Wilson D E. Role of prostaglandins in gastroduodenal mucosal protection. J Clin Gastroenterol 1991; 13(Suppl 1)S65–71
   PubMedGoogle Scholar
• Goren A, Fotherby K J, Shorthouse M, Wight D GD, Hunter J. Campylobacter pylori and acid secretion. Lancet 1989; 212–3
   Google Scholar
• Miller T A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanism. Am J Physiol 1983; 245: G601–23
   PubMed Web of Science ®Google Scholar
• Bright-Asare P, Sontag S J, Gould R, Brand D L, Ronfail W M. Efficacy of misoprostol (twice-daily dosage) in acute healing of duodenal ulcer: a multicentre double-blind controlled trial. Dig Dis Sci 1986; 31: 635–75
   Google Scholar
• Hawkey C J, Walt R P. Prostaglandins for peptic ulcer: a promise unfulfilled. Lancet 1986; 1084–6
   PubMedGoogle Scholar